ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

First Page		Document Content
Date: 2013-10-03 11:33:54 Organochlorides Acetamides Lactams Nonbenzodiazepines Cyclopyrrolones Melatonin Flurazepam Zolpidem Zopiclone Chemistry Organic chemistry Medicine		ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS Add to Reading List Source URL: www.ema.europa.eu Download Document from Source Website File Size: 173,48 KB Share Document on Facebook

	This measure will be used to calculate the CMS 2015 Star Rating using 2013 PDE data. Use of High-Risk Medications in the Elderly (HRM) Description The percentage of patients 65 years of age and older who received two or DocID: 1pGQp - View Document
	s40681BioMedicine (ISSNJune 2016, Vol. 6, No. 2, Article 2, PagesReview article DocID: 1ptdh - View Document
	Use of High-Risk Medications in the Elderly (HRM) Description The percentage of patients 65 years of age and older who received two or more prescription fills for a high-risk medication during the measurement period. De DocID: 1pqJQ - View Document
	This fact demonstrates that the veenat tab combination is safe. Do not drive or do things that you can compare to your doctor has given you. Similarly, chlorpromazine in combination with complementary preparations or vit DocID: 1ougf - View Document
	PDF Created with deskPDF PDF Writer - Trial :: http://www.docudesk.com Generic Specialties, Inc. Psycotropic API’s 1 DocID: 1oto3 - View Document